绘制P-gp在多药物耐药性中的作用:来自最近结构研究的见解
Shi Ting Tia1, Min Luo1,2, Wenjie Fan1
1Department of Biological Sciences, National University of Singapore, Singapore 117558, Singapore.
International journal of molecular sciences
|May 14, 2025
概括
通过将药物从细胞中抽出,P-glycoprotein (P-gp) 在癌症中引起多药性耐药性. 结构研究和患者突变揭示了P-gp活性如何影响化疗失败和耐药性.
科学领域:
- 生物化学 生物化学
- 结构生物学 结构生物学
- 癌症生物学 癌症生物学
背景情况:
- P-glycoprotein (P-gp/ABCB1) 是一个在多药性耐药性 (MDR) 中至关重要的ABC载体.
- 通过从癌细胞中输出抗癌药物,P-gp调解化疗失败.
- 了解P-gp的结构和功能对于克服耐药性至关重要.
研究的目的:
- 审查P-gp最近的结构研究.
- 为了将患者衍生的P-gp突变与功能后果和MDR相关联.
- 探索P-gp抑制策略,以恢复化疗敏感性.
主要方法:
- 结构生物学研究的系统审查,重点是P-gp的冷EM研究.
- 在癌症患者中发现的已知P-gp突变的功能数据分析.
- 整合结构和功能数据以阐明突变驱动的MDR机制.
主要成果:
- Cryo-EM 提供了有关 P-gp 构造状态和传输机制的详细见解.
- 癌症患者中的许多P-gp突变表现出药物流动活性和耐药性表型的改变.
- 结构证据支持突变影响P-gp活性和耐药性的机制.
结论:
- 通过改变药物流量,P-gp突变显著促进化疗耐药性.
- 准P-gp是一种有前途的策略,可以提高癌症治疗效率.
- 对P-gp结构功能关系和抑制的进一步研究对于对抗MDR至关重要.
相关概念视频
The Significance of Membrane Transport
20.7K
The transport of solutes across the cell membrane is essential for metabolic processes, like maintaining cell size and volume, generating the action potential, exchanging nutrients and gases, etc. Membrane transport can be either passive or active. It can be simple diffusion, facilitated, or mediated transport aided by transport proteins such as transporters and channels.
Transporters facilitate either an active or passive movement of solutes. They can allow a single-molecule transport down its...
Transporters facilitate either an active or passive movement of solutes. They can allow a single-molecule transport down its...
20.7K
ABC Transporters: Exporter
4.1K
ATP-binding cassette or ABC transporter is the largest superfamily of integral membrane proteins. The transporters have transmembrane-binding domains (TMDs) and nucleotide-binding domains (NBDs). The TMDs are specific to their substrates, whereas the NBDs are similar to engines that complete ATP hydrolysis to complete the substrate transport. They can be full transporters consisting of two TMDs and NBDs, half transporters with one TMD and NBD, while some encoded with a single TMD or NBD are...
4.1K
Cellular Membranes and Drug Transport
245
Drugs must traverse multiple biological barriers, such as multi-layered skin, single-layered intestinal epithelium, and the plasma membrane, to reach their target sites within the body. The plasma membrane, a highly structured composite of phospholipids, carbohydrates, and proteins, is the cell's protective boundary, facilitating selective substance exchange.
Phospholipids arrange themselves into a bilayer, with hydrophilic heads oriented outward and hydrophobic tails facing inward.
Phospholipids arrange themselves into a bilayer, with hydrophilic heads oriented outward and hydrophobic tails facing inward.
245
Pore Transport and Ion-Pair Transport
316
Pore transport and ion-pair formation are critical mechanisms for the absorption and distribution of drugs in the body.
Pore transport, also known as convective transport, is a process where small molecules like urea, water, and sugars rapidly cross cell membranes as though there were channels or pores in the membrane. Although direct microscopic evidence is limited but the concept of pores or channels is widely accepted based on physiological evidence. Despite the lack of direct...
Pore transport, also known as convective transport, is a process where small molecules like urea, water, and sugars rapidly cross cell membranes as though there were channels or pores in the membrane. Although direct microscopic evidence is limited but the concept of pores or channels is widely accepted based on physiological evidence. Despite the lack of direct...
316
Carrier-Mediated Transport
225
Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
225
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
21
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
21


